Experiment 342415
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Thalictrum dasycarpum (RANUNCULACEAE) |
| Citation | CREAVEN,PJ: COHEN,MH: SELAWRY,OS: TEJADA,F: BRODER,LE:. (1975). PHASE I STUDY OF THALICARPINE (NSC-68075), A PLANT ALKALOID OF NOVEL STRUCTURE.. 59() |
| Amount utilized | |
| Compound isolated | |
| Disease | PHASE I CLINICAL STUDY IN 36 CANCER PATIENTS. MAXIMUM TOLERATED SINGLE DOSE WAS 1.40 GM/SQ. METER BODY SURFACE. NO OBJECTIVE TUMOR RESPONSES OBSERVED. NO IMMUNOSUPPRESSION. RECOMMENDED PHASE II STUDY IN COMBINATION WITH IMMUNOSUPPRESSANT DRUGS. |
| Dose amount | VAR |
| Number | 1 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |